![Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrgastro.2011.21/MediaObjects/41575_2011_Article_BFnrgastro201121_Fig5_HTML.jpg)
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
![Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article](https://assets.cureus.com/uploads/figure/file/236735/lightbox_86a98550df4b11ebafa4d34d891be251-Screen-Shot-2021-07-02-at-12.12.59-AM.png)
Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article
![IJMS | Free Full-Text | Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed IJMS | Free Full-Text | Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed](https://www.mdpi.com/ijms/ijms-18-00962/article_deploy/html/images/ijms-18-00962-g001a.png)
IJMS | Free Full-Text | Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed
![Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis](https://www.frontiersin.org/files/Articles/702929/frph-03-702929-HTML/image_m/frph-03-702929-g001.jpg)
Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis
Full article: Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
![Contraindications for and common side effects of inter- feron alfa and... | Download Scientific Diagram Contraindications for and common side effects of inter- feron alfa and... | Download Scientific Diagram](https://www.researchgate.net/publication/11445125/figure/tbl1/AS:770707394932741@1560762370802/Contraindications-for-and-common-side-effects-of-inter-feron-alfa-and-ribavirin-therapy.png)
Contraindications for and common side effects of inter- feron alfa and... | Download Scientific Diagram
![Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrgastro.2011.21/MediaObjects/41575_2011_Article_BFnrgastro201121_Fig3_HTML.jpg)
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
![Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/483-1/major-pathophysiological-mechanisms-implicated-extrahepatic-manifestations-hcv-infection.jpg)
Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online
![Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet](https://www.thelancet.com/cms/attachment/2001928114/2006662509/gr1.gif)
Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet
![Viruses | Free Full-Text | Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients Viruses | Free Full-Text | Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients](https://www.mdpi.com/viruses/viruses-14-02116/article_deploy/html/images/viruses-14-02116-g001.png)
Viruses | Free Full-Text | Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
Full article: Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
![PDF) Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study PDF) Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study](https://i1.rgstatic.net/publication/313874791_Job_performance_in_chronic_hepatitis_C_virus_patients_treated_with_pegylated_interferon-a2b_plus_ribavirin_an_observational_study/links/58ac5d33a6fdccd53db8b77f/largepreview.png)
PDF) Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
![Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era? Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era?](https://actagastro.org/wp-content/uploads/2017/04/MO-15-051-IMG03.jpeg)